Your browser doesn't support javascript.
loading
Impaired NK cell recognition of vemurafenib-treated melanoma cells is overcome by simultaneous application of histone deacetylase inhibitors.
López-Cobo, Sheila; Pieper, Natalia; Campos-Silva, Carmen; García-Cuesta, Eva M; Reyburn, Hugh T; Paschen, Annette; Valés-Gómez, Mar.
Afiliação
  • López-Cobo S; Department of Immunology and Oncology, National Centre for Biotechnology, CNB-CSIC, Madrid, Spain.
  • Pieper N; Department of Dermatology, University Hospital Essen, University Duisburg-Essen, and German Cancer Consortium (DKTK) partner site Essen/Düsseldorf, Essen; Germany.
  • Campos-Silva C; Department of Immunology and Oncology, National Centre for Biotechnology, CNB-CSIC, Madrid, Spain.
  • García-Cuesta EM; Department of Immunology and Oncology, National Centre for Biotechnology, CNB-CSIC, Madrid, Spain.
  • Reyburn HT; Department of Immunology and Oncology, National Centre for Biotechnology, CNB-CSIC, Madrid, Spain.
  • Paschen A; Department of Dermatology, University Hospital Essen, University Duisburg-Essen, and German Cancer Consortium (DKTK) partner site Essen/Düsseldorf, Essen; Germany.
  • Valés-Gómez M; Department of Immunology and Oncology, National Centre for Biotechnology, CNB-CSIC, Madrid, Spain.
Oncoimmunology ; 7(2): e1392426, 2018.
Article em En | MEDLINE | ID: mdl-29308322
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Oncoimmunology Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Oncoimmunology Ano de publicação: 2018 Tipo de documento: Article